Publications

November 2002
Compilation

Four Principles of Biomedical Ethics: Definitions and Examples

By: Sandra J. Sucher

Introduces four principles of biomedical ethics, excerpted from Principles of Biomedical Ethics, Tom L. Beauchamp and James F. Childress (Oxford University Press, 2001). The principles provide a conceptual framework for the analysis and resolution of moral problems... View Details

Keywords: Framework; Moral Sensibility; Health Care and Treatment; Distribution; Problems and Challenges; Research; Emotions; Management Analysis, Tools, and Techniques; Pharmaceutical Industry; Health Industry

Article

Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study

By: Maryaline Catillon

Keywords: Biomedical Research; R＆D; Innovation; Technology; Drug Trials; RCT; Health; Healthcare; Health Care And Treatment; Health Care Policy; Innovation and Invention; Innovation Strategy; Research and Development; Technological Innovation; Health Industry; Pharmaceutical Industry

Read Now

25 Mar 2016
HBS Seminar

Curtis Keith, Harvard University, Blavatnik Biomedical Accelerator

Trends and Predictors of Biomedical Research Quality, 1990-2015

This work leverages the strengths of expert human assessments of randomized controlled trials (RCTs) included in Cochrane reviews with data science techniques to build a comprehensive database on biomedical research quality. The data links the full-text and... View Details

15 Nov 2002
Conference Presentation

The Biomedical Revolution: From Promise to Reality

By: Gary P. Pisano

Keywords: Science; Transformation

April 2018
Teaching Note

Growing a Cluster: The Singapore Biomedical Sciences Initiative

By: Michael Porter and Christian Ketels

April 2018 (Revised September 2019)
Case

Growing a Cluster: The Singapore Biomedical Sciences Initiative

By: Michael Porter and Christian H.M. Ketels

30 Mar 2017
News

Public Funding Essential for Advances in Biomedical Research

November 2011 (Revised February 2012)
Case

China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise

By: Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki

As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the... View Details

Keywords: Globalized Firms and Management; Research; Corporate Strategy; Pharmaceutical Industry; Health Industry; China

2021
Working Paper

Who Do We Invent for? Patents by Women Focus More on Women's Health, but Few Women Get to Invent

By: Rembrand Koning, Sampsa Samila and John-Paul Ferguson

Has the increase in female medical researchers led to more medical advances for women? In this paper, we investigate if the gender of inventors shapes their types of inventions. Using data on the universe of U.S. biomedical patents, we find that patents with women... View Details

Keywords: Innovation; Biomedical Research; Innovation and Invention; Diversity; Gender; Research; Health; United States

Read Now

29 Apr 2013
News

Harvard to receive $50 million to speed translation of research into therapies

Keywords: biomedical; Colleges, Universities, and Professional Schools; Educational Services; Health, Social Assistance; Scientific Research and Development Services

December 2012 (Revised August 2013)
Case

BMS-Biocon Research Center: Growing a Joint Research Venture in India

By: Vicki Sato, Sen Chai, Rich Ballenger, Christine Chi, Alexander Down and Ross Leimberg

Bristol Myers Squibb, a multi-national pharmaceutical company, is seeking to globalize its R&D strategy while managing costs. It has formed a joint venture with an Indian company, which has worked well, but now faces a strategic decision on how and whether to continue. View Details

Keywords: Pharmaceuticals; Global Innovation; Research And Development; Biomedical Research; Joint Ventures; India; United States

30 Jan 2015
HBS Seminar

Griffin Weber (MD, PhD, Head of the Knowledge Discovery and Management Group, Asst Prof. of Medicine, Center for Biomedical Informatics, Harvard Medical School, Beth Israel Deaconess Medical Center), Harvard Medical School

January 2014
Supplement

Fred Khosravi and AccessClosure (C)

By: Richard Hamermesh and Lauren Barley

On September 11, 2013, the three-judge panel of the U.S. Court of Appeals for the Federal Circuit denied St. Jude's request to rehear an appeal on the "double patenting" ruling for the '439 patent. Further, it removed the injunction threat that was hanging over the... View Details

Keywords: Medical Devices; Vascular Closure Device; Patent Litigation; Patenting; Biomedical Research; Biotechnology; Biotech; Technological Innovation; Patents; Health Care and Treatment; Biotechnology Industry; United States

October 2013 (Revised January 2014)
Supplement

Fred Khosravi and AccessClosure (B)

By: Richard G. Hamermesh and Lauren Barley

It was January 2013, and Fred Khosravi, chairman of the board of AccessClosure Inc., wondered what the new year had in store for him and AccessClosure, the company he founded in late 2002. Khosravi was cautiously optimistic—the Mountain View, California-based medical... View Details

Keywords: Medical Devices; Vascular Closure Device; Patent Litigation; Patenting; Biomedical Research; Biotechnology; Biotech; Technological Innovation; Patents; Health Care and Treatment; Biotechnology Industry; United States; California

September 2024
Case

Myeloma Investment Fund

By: Kyle Myers and Scott Sawaya

This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma. The MIF, a venture philanthropy fund, must choose between two distinct paths. One option... View Details

Keywords: Venture Philanthropy; Biomedical Research; Science Bassed Business; Investing For Impact; Innovation ＆ Entrepreneurship; Venture Capital; Science-Based Business; Biotechnology Industry; Pharmaceutical Industry

September 2013 (Revised August 2014)
Case

Claritas Genomics

By: Robert F. Higgins and Matthew Preble

Claritas Genomics was formed in January 2013 when BCH spun out its Genetics Diagnostic Lab into a fully commercial entity. Claritas offered over 100 genomic tests to detect a range of conditions, including autism and intellectual disabilities, and was developing new... View Details